MIP PHARMA DANMARK ApS: Financial statements 2019
CVR: 32886280
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
MIP PHARMA DANMARK ApS (CVR 32886280) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -23,103 and a net result of DKK -33,370 compared with DKK -34,986 the year before. Equity in the 2019 report amounted to DKK -217,169.
- Gross Profit
- DKK -23,103
- Profit/Loss
- DKK -33,370
- Equity
- DKK -217,169
- Total Assets
- DKK 17,524
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -23 t. | -33 t. | -217 t. | 0 |
| 2018 | - | -27 t. | -35 t. | -184 t. | 0 |
| 2017 | - | -34 t. | -39 t. | -149 t. | - |
| 2016 | - | -34 t. | -43 t. | -109 t. | - |
| 2015 | - | -42 t. | -47 t. | -67 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout MIP PHARMA DANMARK ApS
MIP PHARMA DANMARK ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jochen Steinhage. The company is owned by MIP Pharma GmbH. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -129,052 and a net result of DKK -155,646 compared with DKK -109,135 the year before. Equity in the 2025 report amounted to DKK -716,683.